Skip to main content
Premium Trial:

Request an Annual Quote

Imagining the Future

US News and World Report's Bernadine Healy imagines how cancer will be treated in 2040 and discusses how close we are today to making cancer a chronic disease whose treatment is tailored to the patient. Healy seems hopeful that the Cancer Genome Atlas project will help elucidate the genetic causes of cancer.

Also on the cancer front, David Dooling blogs about a talk given by Memorial Sloan-Kettering's Chris Sander. Sander studies cancer at different biological levels, from SNPs to signaling pathways, and how drugs affect those pathways. "The question still remains however: pathways-level analysis will cover 60-80% of people with a specific sub-type of cancer. What about the other 20-40% whose mutations don’t fall into those pathways?" Dooling asks.


The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.